Melhores Oncologia Hematológica hematologistas-oncologistas em Israel - TOP-28 médicos

Chefe de Hematologia no Sourasky Medical Center – o principal hospital de Israel para o tratamento do cancro do sangue.

• Mais de 25 anos de especialização em hematologia e oncologia
• Formação especializada (Fellowship) no Ronald O Perelman e Claudia Cohen Centre
• Especialista em transplantes de medula óssea e terapias celulares avançadas
• Publicou mais de 90 artigos de investigação em revistas médicas de renome

Várias centenas de transplantes de células-tronco realizados – O Dr. Ram é especialista em casos hematológicos complexos no Sourasky Medical Center.

• Certificação tripla em Hematologia, Oncologia Médica e Medicina Interna
• Treinamento de subespecialidade (Fellowship) no New York Medical College
• Publicou mais de 30 artigos científicos e um capítulo de livro didático
• Foca em técnicas de transplante alogênico e haploidentico

Mais de 300 transplantes pediátricos de medula óssea e sangue do cordão umbilical – O Dr. El Hasid chefia o Departamento de Onco-hematologia Pediátrica do Hospital Infantil Dana Dwek.

• Especializa-se exclusivamente em procedimentos de transplante pediátrico
• Publicou mais de 50 artigos de pesquisa sobre tópicos de hematologia
• Formado no City of Hope Hospital em Los Angeles
• Membro da American Association for Hematology

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Mais de 900 transplantes de medula óssea realizados – O Dr. Michael Shapira é um hematologista líder no Sourasky Medical Center.

• Especializado em transplante de medula óssea no Hadassah Medical Center
• Reconhecido pelo avanço da medicina de transplante
• Fala inglês e hebraico fluentemente
• Graduado pela faculdade de medicina da Universidade Hebraica

O Dr. Dror Levin dirige a hematologia e oncologia pediátrica no Sourasky Medical Center – especializando-se em cancros do sangue e sarcomas em crianças.

• Especialista em transplante de medula óssea pediátrico e terapia com células CAR-T
• Formado no Instituto Ortopédico Rizzoli – um líder global em oncologia óssea
• Coordena os programas de tratamento de sarcomas em Israel para crianças
• Membro da Sociedade Israelense de Hematologia-Oncologia Pediátrica (ISPHO)

O Dr. Kirshner lidera ensaios clínicos de fase III para cancros resistentes no Sourasky Medical Center, trazendo tratamentos de ponta aos pacientes.

• Dupla subespecialização (fellowship) em hematologia e oncologia médica em Montefiore
• Especialista em linfoma folicular resistente ao tratamento e anemia aplástica
• Membro da Sociedade Americana de Hematologia
• Mais de 25 anos de experiência em hematologia e oncologia
• Certificado em medicina interna e oncologia

Chefe do Instituto de Hemato-Oncologia do Sourasky Medical Center – O Dr. Aviv é especializado em cancros do sangue complexos e transplantes de medula óssea.

• Mais de 30 anos focados exclusivamente em onco-hematologia
• Lidera o Departamento de Transplante de Medula Óssea
• Especialista em terapia com células CAR-T e imunoterapia
• Atua no principal centro de oncologia de Israel

O Dr. Herishanu Yair é um hematologista de renome com mais de 10 prémios por investigação inovadora em leucemia linfocítica crónica (LLC) no Sourasky Medical Center.

• Especialista em LLC – a leucemia mais comum em adultos
• Recipiente do prestigiado Prémio de Oncologia Klitzberg
• Membro das associações de hematologia israelita e americana
• Formação extensiva em instituições médicas de topo em Israel
• Investigador publicado com bolsas da Fundação de Ciência de Israel

Listado pela Forbes como um dos melhores médicos de Israel – o Dr. Goldstein lidera a Oncologia Pediátrica no Hadassah Medical Center.

• Especializado em hemato-oncologia pediátrica há mais de 20 anos
• Especialista em retinoblastoma e abordagens de medicina de precisão
• Realiza transplantes de medula óssea haploidênticos para crianças
• Membro de quatro associações internacionais de oncologia pediátrica

O Prof. Reuven Or lidera o Departamento de Hematologia e Transplante de Medula Óssea do Hadassah – pioneiro em imunoterapia do cancro e terapia celular.

• Mais de 15 anos de especialização em transplantes de medula óssea e cancros hematológicos
• Diretor Médico do Banco Nacional de Sangue de Israel e do Registo Público de Medula Óssea
• Destinatário do prestigiado Prémio Menachem Begin por conquistas médicas
• Formado em instituições de topo em Itália e nos EUA
• Publicou vários artigos de investigação em revistas médicas

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.